The clinicopathological significance of inferior mesenteric lymph node metastasis in colorectal cancer
- 1 April 2004
- journal article
- research article
- Published by Elsevier BV in European Journal of Surgical Oncology
- Vol. 30 (3), 271-279
- https://doi.org/10.1016/j.ejso.2003.12.002
Abstract
There are few studies reporting survival or recurrence patterns in colorectal cancer patients with inferior mesenteric lymph node metastasis (IMLN+). The present study evaluated the prognostic significance of patients being IMLN+ or IMLN- in colorectal cancer. Survival, recurrence pattern and treatment protocols were compared between 63 IMLN+ patients and 108 IMLN- patients with stage III and IV rectal and sigmoid cancer undergoing curative surgery. Lymph node sampling was routinely performed prior to inferior mesenteric artery ligation and excision flush with aorta. Limited principal node dissection including IMLN was performed in cases of identified node metastasis. The 5-year disease-free survival rates were 50% in IMLN- and 31% in IMLN+ patients (P=0.004). The 5-year disease-free survival rate was greater in the N1 group than the N2 group (P=0.038). Cox regression analysis showed IMLN+, lymphovascular tumour invasion, T4, M1, and pre-operative serum CEA level over 6 ng/ml were independently associated with unfavorable disease-free survival. The prognostic significance of M category was greater when the IMLN+ was included in the M1 as opposed to the N category. In patients undergoing absolute curative surgery, post-operative recurrence rates were 34% for IMLN- and 57% for IMLN+ patients (P=0.009; OR, 2.611; 95% CI, 1.313-5.194). For IMLN+ patients, post-operative adjuvant treatment independently correlated with disease-free survival (P=0.029). IMLN+ is an independent survival factor enhancing the prognostic significance of the M category in the AJCC staging. Curative radical surgery and post-operative chemoradiotherapy appears to be warranted for IMLN+ colorectal cancer patients as it resulted in 5-year disease-free survival rates of up to 31% compared to 50% in IMLN- patients.Keywords
This publication has 30 references indexed in Scilit:
- Patterns of lymphatic spread in rectal cancer. A topographical analysis on lymph node metastasesEuropean Journal Of Cancer, 2002
- Prognostic Determinants of Patients With Lateral Nodal Involvement by Rectal CancerAnnals of Surgery, 2001
- Indication for using high ligation of the inferior mesenteric artery in rectal cancer surgeryDiseases of the Colon & Rectum, 1998
- Distribution of Lymph Node Metastasis and Level of Inferior Mesenteric Artery Ligation in Colorectal CancerJournal of Clinical Gastroenterology, 1998
- Mesorectal excision for rectal cancerThe Lancet, 1993
- High versus low ligation of the inferior mesenteric artery in rectal cancerBritish Journal of Surgery, 1990
- A multivariate analysis of clinical and pathological variables in prognosis after resection of large bowel cancerBritish Journal of Surgery, 1985
- Survival After High or Low Ligation of the Inferior Mesenteric Artery During Curative Surgery for Rectal CancerAnnals of Surgery, 1984
- Large bowel cancer: Surgical pathology and its relationship to survivalBritish Journal of Surgery, 1984
- Extensive lymphadenectomy and high ligation of the inferior mesenteric artery for carcinoma of the left colon and rectumDiseases of the Colon & Rectum, 1958